Quantcast
Channel: myMeso » orphan drug
Browsing latest articles
Browse All 4 View Live

Quintessence continues with mesothelioma drug

On April 21 I reported that a Madison, Wisconsin-based biotechnology firm, Quintessence Bioscience, was moving forward on a drug similar to Alfacel’s Onconase, to treat mesothelioma. The report, from...

View Article



Image may be NSFW.
Clik here to view.

Arenegyr granted orphan drug status

Friday it was announced the European Commission has granted orphan drug status for Arenegyr, an anti-tumor therapeutic drug manufactured by MolMed S.p.A. in the treatment of malignant pleural...

View Article

Image may be NSFW.
Clik here to view.

New mesothelioma drug granted orphan status from EU

Drug maker Verastem Inc. has obtained approval from the European Commission to proceed with the development of a potential new mesothelioma treatment, which has been granted orphan status. Orphan...

View Article

Image may be NSFW.
Clik here to view.

COMMAND clinical trial treating patients with malignant pleural mesothelioma

Drug manufacturer Verastem, Inc., has initiated a registration-directed, double-blind, placebo-controlled clinical trial for patients with malignant pleural mesothelioma. The trial is a...

View Article
Browsing latest articles
Browse All 4 View Live




Latest Images